Substance use and survival after treatment for chronic myelogenous leukemia (CML) or myelodysplastic syndrome (MDS).

@article{Chang2010SubstanceUA,
  title={Substance use and survival after treatment for chronic myelogenous leukemia (CML) or myelodysplastic syndrome (MDS).},
  author={Grace C Chang and M K Meadows and Jennifer A. Jones and Joseph H Antin and E. John Orav},
  journal={The American journal of drug and alcohol abuse},
  year={2010},
  volume={36 1},
  pages={1-6}
}
BACKGROUND Patients' substance use problems are a particularly understudied aspect of psychosocial variables in cancer treatment. OBJECTIVES The specific hypothesis tested was that lifetime substance use disorders increased the risk of adverse outcome, in the context of other psychosocial and clinical characteristics demonstrated in other studies to have an impact on treatment outcome. METHOD Prospective cohort study of 106 adults with chronic myelogenous leukemia or primary myelodysplastic… CONTINUE READING

Similar Papers

Loading similar papers…